Lakeshore Biopharma (NASDAQ:LSB) Stock Price Down 1.4% – What’s Next?

Lakeshore Biopharma Co., Ltd. (NASDAQ:LSB) shares were down 1.4% during trading on Tuesday . The stock traded as low as $3.47 and last traded at $3.50. Approximately 25,652 shares changed hands during trading, a decline of 6% from the average daily volume of 27,263 shares. The stock had previously closed at $3.55.

Lakeshore Biopharma Trading Down 19.7 %

The company has a quick ratio of 0.87, a current ratio of 1.13 and a debt-to-equity ratio of 0.17. The stock has a fifty day moving average price of $2.81.

Institutional Investors Weigh In On Lakeshore Biopharma

A number of hedge funds and other institutional investors have recently modified their holdings of the company. FMR LLC acquired a new stake in shares of Lakeshore Biopharma during the 3rd quarter worth about $803,000. Hhlr Advisors LTD. acquired a new position in Lakeshore Biopharma in the third quarter valued at approximately $513,000. Finally, Barclays PLC purchased a new position in Lakeshore Biopharma in the third quarter valued at approximately $169,000. 52.64% of the stock is currently owned by institutional investors and hedge funds.

About Lakeshore Biopharma

LakeShore Biopharma Co, Ltd, a biopharmaceutical company, engages in discovering, developing, manufacturing, and commercializing of vaccines and therapeutic biologics for infectious diseases and cancer. The company develops a proprietary PIKA immunomodulating technology platform and a series of product targeting PIKA rabies vaccine, PIKA recombinant COVID-19 vaccine, and PIKA YS-ON-001.